Full-Time

Territory Sales Representative

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

Compensation Overview

$105k - $195k/yr

Boston, MA, USA + 4 more

More locations: Manchester, NH, USA | Providence, RI, USA | Waltham, MA, USA | Worcester, MA, USA

In Person

Travel approximately 70% in MA/NH/RI; on-site visits may be required.

Category
Sales & Account Management (1)
Required Skills
Sales
Data Analysis

Get referred to Inizio Engage

See people who can refer or advise you

Requirements
  • Bachelor's degree required, preferably in Business, Life Sciences, or a related field.
  • Minimum of 3–5 years of pharmaceutical, biotechnology, or healthcare sales experience.
  • Experience calling on hospitals, integrated delivery networks (IDNs), specialty pharmacies, physician offices, infusion providers, or other institutional healthcare customers preferred.
  • Acute care, specialty biologics, immunology, or buy-and-bill experience preferred.
  • Demonstrated success building customer relationships, managing a sales territory, and achieving business objectives.
  • Strong business acumen, communication, presentation, and relationship-building skills.
  • Experience using CRM systems and leveraging customer insights to manage territory performance.
  • Ability to manage a large geographic territory with approximately 70% travel.
Responsibilities
  • Develop and execute strategic and tactical account plans for assigned hospitals, health systems, integrated delivery networks (IDNs), outpatient infusion centers, and large outpatient pharmacy accounts.
  • Build and maintain strong relationships with physicians, pharmacy leaders, hospital administrators, purchasing teams, specialty distributors, and key healthcare decision-makers.
  • Conduct compliant clinical and business discussions to educate customers on disease states, product benefits, and appropriate product utilization.
  • Navigate complex healthcare organizations to understand account structures, decision-making processes, customer needs, and treatment pathways.
  • Identify new business opportunities while expanding relationships within existing accounts to support territory growth.
  • Analyze territory performance, customer insights, market trends, and competitive activity to develop and adjust territory strategies.
  • Maintain accurate CRM documentation, account plans, forecasts, customer interactions, and territory records.
  • Collaborate with Sales Leadership, Medical Affairs, Market Access, Marketing, National Accounts, and other cross-functional partners to deliver coordinated customer solutions.
  • Attend local, regional, and national meetings, product training, and industry conferences.
  • Manage the assigned territory with a high degree of professionalism, compliance, and accountability while consistently delivering an exceptional customer experience.

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Get referred to Inizio Engage

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Patient Access Services expands support across specialty, rare, and orphan diseases.[7]
  • Nazaré's AI Academy should increase client adoption of AI-enabled workflows.[8]
  • International footprint across multiple regions supports multinational pharma programs.[5][8]

What critics are saying

  • Pharma clients are shifting commercial operations in-house, compressing outsourced engagement demand.
  • Platform competitors bundle analytics, education, and field support into cheaper integrated contracts.
  • Regulatory and compliance failures can trigger immediate client termination in healthcare engagements.

What makes Inizio Engage unique

  • Global healthcare engagement partner with 30+ years in pharma commercialization.[1][2]
  • Propensity4 turns disparate data into integrated insight platforms for commercial decisions.[3]
  • Inizio Engage XD packages employee engagement, learning, events, film, digital, and behavioral science.[8]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMLiVE
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMLiVE
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

Haymarket Media
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.